Anrate Recombinant Human Transferrin ART201S (Apo‑TF) & ART202 (Holo‑TF) — Reliable Raw Material for Media Manufacturers

Replace plasma‑derived transferrin with Anrate recombinant human transferrin. Expressed from Pichia pastoris, ART201S (Apo‑TF) and ART202 (Holo‑TF) are 100% animal‑origin‑free, blood‑free protein supplements tailored for serum‑free and chemically‑defined media formulation. Low endotoxin, high purity and stable iron‑binding activity reduce process variability for media developers and bioproduction partners.

Two Product Variants for Media Design

ART201S Apo‑Transferrin(Apo‑TF) Iron‑free form, ideal for media systems where iron concentration needs precise control. Suitable for custom‑formulated CD‑media with adjustable iron sources.

ART202 Holo‑Transferrin(Holo‑TF) Iron‑saturated form, provides direct bio‑available iron source for cell culture. Simplify medium recipes by reducing extra iron‑salt addition.

Key Benefits for Media Companies

Animal‑origin‑free & blood‑free:Eliminate adventitious agent risks brought by plasma‑isolated transferrin, simplify regulatory documentation preparation.

Superior batch‑to‑batch consistency:Recombinant manufacturing process minimizes lot variation, stabilizes medium performance in mass production.

Low endotoxin & high purity ≥98%:Strict quality control meets industrial biomanufacturing requirements.

Two‑variant portfolio:Apo‑TF and Holo‑TF available to support diverse media R&D goals.

Scalable supply capacity:Support small‑scale R&D to large‑volume industrial orders, complete quality documents provided.

Anrate ART201S Apo‑Transferrin & ART202 Holo‑Transferrin, Pichia pastoris‑expressed. Animal‑origin‑free, low‑endotoxin with high batch‑to‑batch consistency. Core raw materials for serum‑free & chemically‑defined media. Request datasheets and samples.